(VRTX) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
February 10, 2010
(Fusion Investing and Analysis,
12/30/09)
Is the one I'm currently buying.
(Stock Blog Hub,
10/28/09)
Vertex Pharmaceuticals (VRTX) posted a loss of 83 cents per share in the third quarter, 3 cents wider than the Zacks Consensus Estimate of a loss of 80 cents. The company posted a...(read more)
(Fusion Investing and Analysis,
7/30/09)
Vertex Pharmaceuticals and Mitsubishi Tanabe Pharma Corporation Amend Agreement to Develop and Commercialize Telaprevir in Asia
Vertex to receive $105 million from Mitsubishi following signing,...(read more)
Vertex Pharmaceuticals (VRTX) Company Overview
There is no analysis for VRTX yet. But you can go to Wikinvest to help create one! What's in this VRTX analysis on Wikinvest...
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. By accessing this page, you agree to the following terms and conditions. Conference calls info supplied by OpenCompany Fundamental data supplied by Morningstar Stock quotes supplied by Telekurs USA |
|
